Martin Löwer
6Patents
2h-index
16Co-inventors
40Inventor score
Filing activity: May 23, 2012 → Jul 2, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10738355B2 | Individualized vaccines for cancer | Emerging Cross-Sectional Technologies | 35 | Active |
| US11222711B2 | Predicting immunogenicity of T cell epitopes | Chemistry; Metallurgy | 9 | Active |
| US11248264B2 | Individualized vaccines for cancer | Emerging Cross-Sectional Technologies | 2 | Active |
| US11156617B2 | Predicting T cell epitopes useful for vaccination | Physics | 1 | Active |
| US12153041B2 | Methods for predicting the usefulness of proteins or protein fragments for immunotherapy | Physics | 0 | Active |
| US11920194B2 | Methods for characterizing loss of antigen presentation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.